WNT signalling is both an inducer and effector of glucagon-like peptide-1.
Gustafson
B
B
The Lundberg Laboratory for Diabetes Research, Center of Excellence for Metabolic and Cardiovascular Research, Department of Molecular and Clinical Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Smith
U
U
D000818:Animals; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism*; D006801:Humans; D008954:Models, Biological; D015398:Signal Transduction / Q000502:physiology*; D051153:Wnt Proteins / Q000502:physiology*
D051153:Wnt Proteins; D052216:Glucagon-Like Peptide 1